| 000 | 01671 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513205415.0 | ||
| 264 | 0 | _c20000509 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 024 | 7 |
_a10.4049/jimmunol.164.8.4150 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFraser, S A | |
| 245 | 0 | 0 |
_aPerforin lytic activity is controlled by calreticulin. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cApr 2000 |
||
| 300 |
_a4150-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCalcium-Binding Proteins _xchemistry |
| 650 | 0 | 4 | _aCalreticulin |
| 650 | 0 | 4 |
_aCalsequestrin _xpharmacology |
| 650 | 0 | 4 | _aChymases |
| 650 | 0 | 4 |
_aCytotoxicity, Immunologic _xdrug effects |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPerforin |
| 650 | 0 | 4 | _aPore Forming Cytotoxic Proteins |
| 650 | 0 | 4 |
_aProtein Structure, Tertiary _xphysiology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred F344 |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 650 | 0 | 4 |
_aRibonucleoproteins _xchemistry |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aKarimi, R | |
| 700 | 1 | _aMichalak, M | |
| 700 | 1 | _aHudig, D | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 164 _gno. 8 _gp. 4150-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.164.8.4150 _zAvailable from publisher's website |
| 999 |
_c10707644 _d10707644 |
||